PUYOU de POUVOURVILLE Gérard
Department : Economics
Emeritus Professor
Campus de Cergy
Contact
- email : pouvourville@essec.edu
- tél : +33 (0)1 34 43 30 10
Diplomas
- 1978 : Doctorate in Economics and Business Administration (Université d'Aix-Marseille, France)
- 1974 : Diplôme d'Etudes Supérieures in Economics (Université Paris 1 Panthéon-Sorbonne, France)
- 1970 : Graduate (École Polytechnique, France)
Career
- 2019 - Present : Emeritus Professor (ESSEC Business School, France)
- 2007 - 2019 : Professor (ESSEC Business School, France)
- 2000 - 2006 : Head of the Etudes Médico-Economiques, part-time role (Institut Gustave Roussy, France)
- 2000 - 2006 : Lecturer, with Monique Kerleau, "Approche économique et théorie des organisations appliquées au système de soins", DESS Economie et Gestion des systèmes de santé (Université Paris 1 Panthéon-Sorbonne, France)
- 2000 - 2006 : Supervisor of Economics and Management courses, Master Santé Publique, M1 (University Paris-Saclay, France)
- 2000 - 2006 : Track Head, "Economie de la Santé", Master 2 Santé Publique. Teaching and Dissertation mentoring (University Paris-Saclay, France)
- 2003 - 2006 : Head of the Research Program « Epidémiologie, Santé Publique, Economie de la Santé et Sciences Humaines et Sociales », at the Direction de la Recherche (Institut Gustave Roussy, France)
- 2004 - 2006 : Lecturer, Module « Préparation à la vie professionnelle », DCEM2, Faculté de Médecine de Bicêtre (University Paris-Saclay, France)
- 2006 : Research teams manager, CERMES, INSERM U750, CNRS UMR 8169 (Institut national de la santé et de la recherche médicale (INSERM), France)
- 2000 - 2005 : Head of the Centre de Recherche en Economie et Gestion Appliquées à la Santé, INSERM U537, CNRS UMR 8052. (Institut national de la santé et de la recherche médicale (INSERM), France)
- 1998 - 2001 : Associate Professor, Université de Lausanne (HEC Lausanne, Switzerland)
- 1993 - 2000 : Scientific Director of Groupe Information Médicale et Aide à la Gestion des Etablissements (IMAGE); by the CNRS. (École Nationale de la Santé Publique, France)
- 1994 - 1999 : Lecturer, Faculté de Médecine Saint-Louis-Lariboisière; teacher for the DEA "Système de soins hospitaliers et Société" (Director: Dominique Bertrand). Seminar "Evaluation des coûts à l'hôpital", seminar (with Alain Fontaine) "Préparation du mémoire de DEA". (Université Paris Cité, France)
- 1986 - 1993 : Lecturer; DEA 103 "Méthodes Scientifiques de Gestion" (Professor Bernard Roy) (Université Paris-Dauphine, PSL University, France)
- 1989 - 1993 : Research Director, 2nd class, Centre de Recherche en Gestion (École Polytechnique, France)
- 1989 - 1992 : Research fellow, Groupe IMAGE (École Nationale de la Santé Publique, France)
- 1981 - 1989 : Research fellow, CNRS, Centre de Recherche en Gestion (École Polytechnique, France)
- 1986 : Invited Researcher at Groupe de Recherche Interdisciplinaires en Santé (GRIS). Expert invited at the Commission d'Enquête sur les Services Sociaux et de Santé, Gouvernement du Québec. (Université de Montréal, Canada)
- 1984 : Guest Researcher, Leonard Davis Institute for Health Economics (University of Pennsylvania, United States of America)
- 1978 - 1981 : Researcher, Centre de Recherche en Gestion (École Polytechnique, France)
- 1979 - 1980 : Part-time lecturer, Institut Auguste Comte pour l'Etude des Sciences de l'Action. (École Polytechnique, France)
- 1973 - 1978 : Doctorate, Centre de Recherche en Gestion (École Polytechnique, France)
- 1973 - 1977 : Economics class lecturer. In charge of the organization of final internships in Economics and Management. (École Polytechnique, France)
- 1976 - 1977 : Economics classes lecturer (École Nationale du Génie Rural et des Eaux et Forêts (ENGREF), France)
Full-time academic appointments
Other Academic Appointments
Journal articles
- GUERCI, B., ROUSSEL, R., LEVRAT-GUILLEN, F., DETOURNAY, B., VICAUT, E., PUYOU DE POUVOURVILLE, G. ... RIVELINE, J.P. (2023). Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre® system initiation in people with type 2 diabetes on basal insulin therapy in France. Diabetes Technology & Therapeutics, 25(1), pp. 1-30.
- GAUTIER, L., AZZI, J., SABA, G., BONNELYE, G. and PUYOU DE POUVOURVILLE, G. (2023). Population norms in France with EQ-5D-5L: health states, value indexes, and VAS. European Journal of Health Economics, In press.
- PUYOU DE POUVOURVILLE, G., ARMOIRY, X., LAVOREL, A., BILBAULT, P., MAUGENDRE, P., BENSIMON, L. ... VIPREY, M. (2023). Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials? Therapies, 78(1), pp. 81-94.
- PUYOU DE POUVOURVILLE, G., CUNNINGHAM, D., FRICKE, F.U., LINDGREN, P. and MANTOVANI, L. (2023). Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study. Value in Health, In press.
- WANG, W., KOTHARI, S., KHOURY, H., NICCOLAI, L., GARLAND, S.M., SUNDSTRÖM, K. ... FRANCO, E.L. (2023). A review of data systems for assessing the impact of HPV vaccination in selected high-income countries. Expert Review of Vaccines, 22(1), pp. 161-179.
- HENSHALL, C.H., DANKÓ, D., BARHAM, L., ESPÍN, J., FELIX, J., HARNEY, M. ... WILKING, N. (2023). Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe. Applied Health Economics and Policy, In press.
- SMITH, A., HANBURY, A., WHITTY, J., BEITIA ORTIZ DE ZARATE, I., PUYOU DE POUVOURVILLE, G., HAMMES, F. and BUESCH, K. (2022). A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France. Patient Related Outcome Measures, (13), pp. 21-30.
- THURIN, N., ROUYER, M., JOVÉ, J., GROSS-GOUPIL, M., HAASER, T., REBILLARD, X. ... BLIN, P. (2022). Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database. Expert Review of Clinical Pharmacology, 15(9), pp. 1139-1145.
- WITHALL, A., JOMMI, C., PUYOU DE POUVOURVILLE, G., TAYLOR, D., ANNEMANS, L., SCHOONAERT, L. ... PATRIS, J. (2022). Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework. International Journal of Technology Assessment in Health Care, 38(1), pp. e23, 1-8.
- GILARD, M., ELTCHANINOFF, H., IUNG, B., LEFÈVRE, T., SPAULDING, C., DUMONTEIL, N. ... SHORE, J. (2022). Cost-Effectiveness Analysis of SAPIEN 3 Transcatheter Aortic Valve Implantation Procedure Compared With Surgery in Patients With Severe Aortic Stenosis at Low Risk of Surgical Mortality in France. Value in Health, 25(4), pp. 605-613.
- RIVELINE, J.P., ROUSSEL, R., VICAUT, E., PUYOU DE POUVOURVILLE, G., DETOURNAY, B., EMERY, C. ... GUERCI, B. (2022). Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study. Diabetes Technology & Therapeutics, 24(9), pp. 611-618.
- DALON, F., MAJED, L., BELHASSEN, M., JACOUD, F., BÉRARD, M., LÉVY-BACHELOT, L. ... BALDAUF, J.J. (2021). Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study. Vaccine, 39(36), pp. 5129-5137.
- SMITH, A.B., HANBURY, A., BEITIA ORTIZ DE ZARATE, I., HAMMES, F., PUYOU DE POUVOURVILLE, G. and BUESCH, K. (2021). Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France. Patient Related Outcome Measures, 12, pp. 237-246.
- ROUSSEL, R., RIVELINE, J.P., VICAUT, E., PUYOU DE POUVOURVILLE, G., DETOURNAY, B., EMERY, C. ... GUERCI, B. (2021). Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study. Diabetes Care, 44(6), pp. 1368-1376.
- RICHARD, M., PAUL, C., PUYOU DE POUVOURVILLE, G., JULLIEN, D., MAHE, E., BACHELEZ, H. ... EZZEDINE, K. (2021). Out‐of‐pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross‐sectional, non‐comparative, multicentre study. Journal of the European Academy of Dermatology and Venereology, 35(4), pp. 912-918.
- PUYOU DE POUVOURVILLE, G. (2021). Logique médicale, économique, industrielle et politique dans la définition du « prix » du médicament. Revue d’Économie Financière, 2021/3(143), pp. 213-229.
- DE POUVOURVILLE, G., BLIN, P. and KARAM, P. (2020). The Contribution of Real-World Evidence to Cost-Effectiveness Analysis: Case Study of Dabigatran Etexilate in France. European Journal of Health Economics, 21, pp. 235-249.
- ANDRADE, L.F., LUDWIG, K., RAMOS GONI, J.M., OPPE, M. and DE POUVOURVILLE, G. (2020). A French Value Set for the EQ‐5D‐5L. Pharmacoeconomics, 38(1), pp. 1-13.
- TÉHARD, B., DETOURNAY, B., BORGET, I., ROZE, S. and PUYOU DE POUVOURVILLE, G. (2020). Value of a QALY for France: A New Approach to Propose Acceptable Reference Values. Value in Health, 23(8), pp. 985-993.
- QUINN, C., GARRISON, L.P., POWNELL, A.K., ATKINS, M.B., PUYOU DE POUVOURVILLE, G., HARRINGTON, K. ... WU, E. (2020). Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective. Journal for ImmunoTherapy of Cancer, 8(2), pp. e000648.
- GOODALL, G., LAMOTTE, M., RAMOS, S., MAUNOURY, F., PEJCHALOVA, B. and DE POUVOURVILLE, G. (2019). Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients. Journal of Medical Economics, 22(4), pp. 289-296.
- CHOUAID, C., GERMAIN, N., PUYOU DE POUVOURVILLE, G., ABALLEA, S., KORCHAGINA, D. and BALDWIN, M. (2019). Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Current Medical Research and Opinion, 35(5), pp. 785-792.
- DE POUVOURVILLE, G. and KARAM, P. (2019). Le coût hospitalier des événements cérébro-vasculaires associés à une fibrillation atriale en France. Journal de Gestion et d'Économie de la Santé, 37(5), pp. 399-409.
- PUYOU DE POUVOURVILLE, G. (2016). Anticoagulants d'action directe: une revue de la littérature des études coût/efficacité en Europe. Archives of Cardiovascular Diseases Supplements, 8(2), pp. 180-191.
- PERSONNE, V., CHEVALIER, J., BUFFEL DU VAURE, C., PARTOUCHE, H., GILBERG, S. and DE POUVOURVILLE, G. (2016). CAPECO: Cost Evaluation of Community Acquired Pneumonia Managed in Primary Care. Vaccine, 19(34), pp. 2275-2280.
- PUYOU DE POUVOURVILLE, G. (2016). Comment Améliorer le Suivi des AVK et pour quel Coût? Archives of Cardiovascular Diseases Supplements, 8(2), pp. 169-173.
- PUYOU DE POUVOURVILLE, G. (2016). Coût de la Prise en Charge des Accidents Vasculaires Cérébraux en France. Archives of Cardiovascular Diseases Supplements, 8(2), pp. 161-168.
- PUYOU DE POUVOURVILLE, G. (2016). La Tarification à l’Activité est-elle Compatible avec les Valeurs des Professionnels de Santé ? Médecine de l’Homme, (15), pp. 11-25.
- PUYOU DE POUVOURVILLE, G. (2016). Quel prix payer pour un bénéfice en santé ? SEP et Neurosciences, (5), pp. 4-11.
- COHEN, A. and PUYOU DE POUVOURVILLE, G. (2016). Rapport coût/efficacité des traitements médicamenteux et interventionnels dans la fibrillation atriale. Archives of Cardiovascular Diseases Supplements, 8(2), pp. 141-143.
- BELHASSEN, M., DE BLIC, J., LAFOREST, L., LAIGLE, V., CHANUT-VOGEL, C. and DE POUVOURVILLE, G. (2016). Recurrent Wheezing in Infants. Medicine, 95(15).
- DRUMMOND, M., PUYOU DE POUVOURVILLE, G., JONES, E., HAIG, J., SABA, G. and CAWSTON, H. (2014). A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France. Pharmacoeconomics, 32(5), pp. 509-520.
- BONASTRE, J., CHEVALIER, J., VAN DER LAANC, C., DELIBESC, M. and PUYOU DE POUVOURVILLE, G. (2014). Access to Innovation: Is there a Difference in the Use of Expensive Anticancer Drugs Between French Hospitals? Health Policy, 116(2&3), pp. 162-169.
- PUYOU DE POUVOURVILLE, G. (2013). Editorial: HAS to be NICE? European Journal of Health Economics, 14, pp. 363-366.
- PUYOU DE POUVOURVILLE, G. (2013). Editorial: Paying Doctors for Performance. European Journal of Health Economics, 14(1), pp. 1-4.
- CHEVALIER, J., GIROUD, M. and PUYOU DE POUVOURVILLE, G. (2013). Modeling of the Impact on Health Outcomes of the Use of Dabigatran in Patients with Atrial Fibrillation. Cerebrovascular Diseases, 35(4), pp. 320-326.
- RENARD, J.P., ROULAND, J.F., BRON, A., SELLEM, E., NORDMANN, J.P. and DE POUVOURVILLE, G. (2013). Nutritional, Lifestyle and Environmental Factors in Ocular Hypertension and Primary Open-Angle Glaucoma: An Exploratory Case-Control Study. Acta Ophthalmologica, 61(6), pp. 505-513.
- GARRISON, L.P., TOWSE, A., BRIGGS, A., PUYOU DE POUVOURVILLE, G., GRUEGER, J. and MOHR, P.E. (2013). Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force. Value in Health, 16(5), pp. 703-719.
- LUPORSI, E., MAHI, L., MORRE, C., WERNLI, J., PUYOU DE POUVOURVILLE, G. and BUGAT, R. (2012). Evaluation of Cost Savings with Ferric Carboxymaltose in Anemia Treatment Through Its Impact on Erythropoiesis-Stimulating Agents and Blood Transfusion: French Healthcare Payer Perspective. Journal of Medical Economics, 15(2), pp. 225-232.
- SMOLDEREN, K.G., WANG, K., PUYOU DE POUVOURVILLE, G., BRÜGGENJÜRGEN, B., RÖTHER, J. and ZEYMER, U. (2012). Two-Year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease. European Journal of Vascular and Endovascular Surgery, 43(2), pp. 198-207.
- PUYOU DE POUVOURVILLE, G., ULMANN, P., NIXON, J., BOULENGER, S., GLANVILLE, J. and DRUMMOND, M. (2012). The Diffusion of Health Economics Knowledge in Europe. Pharmacoeconomics, 23(2), pp. 113-120.
- COTTE, F.E. and PUYOU DE POUVOURVILLE, G. (2011). Cost of Non-Persistence with Oral Biphosphonates in Post-Menopausal Osteoporosis Treatment in France. BMC Health Services Research, 151(11), pp. 1-10.
- PUYOU DE POUVOURVILLE, G. (2011). L'assurance maladie en France: Beveridge et Bismarck enfin reconciliés? Réalités Industrielles (série des "Annales des Mines"), pp. 19-24.
- COHEN, S.Y., SOUIED, E.H., WEBER, A.P., DUPEYRON, G., PUYOU DE POUVOURVILLE, G. and LIEVRE, M. (2011). Patient Characteristics and Treatment of Neovascular Age-related Macular Degeneration in France: The LUEUR 1 Observational Study. Graefe's Archive for Clinical and Experimental Ophthalmology, 249(4), pp. 521-527.
- BONASTRE, J., LE VAILLANT, M. and PUYOU DE POUVOURVILLE, G. (2011). The Impact of Research on Hospital Costs of Care: An Empirical Study. Health Economics, 20(1), pp. 73-84.
- CHEVALIER, J. and PUYOU DE POUVOURVILLE, G. (2011). Valuing EQ-5D using Time Trade-Off in France. European Journal of Health Economics, 14(1), pp. 57-66.
- PUYOU DE POUVOURVILLE, G. (2010). Editorial: A French Approach to Cost-Effectiveness Analysis? European Journal of Health Economics, 11(6), pp. 521-523.
- CARO, J.J., NORD, E., MCGUIRE, A., MCGREGOR, D.H., PUYOU DE POUVOURVILLE, G. and ATELLA, V. (2010). IQWiG Methods – A Response to Two Critiques. Health Economics, 19(10), pp. 1137-1138.
- PUYOU DE POUVOURVILLE, G. (2010). La crise d'identité des médecins face au nouveau management de l'hôpital. Journal de l'Ecole de Paris du Management, 6(86), pp. 22-29.
- CARO, J.J., NORD, E., SIEBERT, U., MCGUIRE, A., MCGREGOR, M. and DE POUVOURVILLE, G. (2010). The Efficiency Frontier Approach to Economic Evaluation of Health-Care Interventions. Health Economics, 19(10), pp. 1117-1127.
- COTTE, F.E., FAUTREL, B. and PUYOU DE POUVOURVILLE, G. (2009). A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis. Medical Decision Making, 29(1), pp. 125-139.
- CLERC, P., LE BRETON, J., MOUSQUES, J., HEBBRECHT, G. and PUYOU DE POUVOURVILLE, G. (2009). Etude polychrome : une méthode d'expertise pour optimiser des vignettes de polyprescription en médecine générale. Pratiques et Organisation des Soins, 40(3), pp. 165-174.
- PUYOU DE POUVOURVILLE, G. (2009). Exploitation seconde de la base de l'Etude nationale de coûts (ENC). Dossiers Solidarité et santé, (9), pp. 2-6.
- NIXON, J., RICE, S., DRUMMOND, M., BOULENGER, S., ULMANN, P. and DE POUVOURVILLE, G. (2009). Guidelines for Completing the EURONHEED Transferability Information Checklists. European Journal of Health Economics, 10(2), pp. 157-165.
- PUYOU DE POUVOURVILLE, G. (2009). Les hôpitaux français face au paiement prospectif au cas. La mise en œuvre de la tarification à l'activité. Revue Economique, 60(2), pp. 457-470.
- TIBI-LEVY, Y. and PUYOU DE POUVOURVILLE, G. (2009). Qu'est-ce qu'une unité de soins "performante", du point de vue des malades relevant de soins palliatifs et de leurs proches ? Médecine palliative, 8(2), pp. 53-65.
- DEJARDIN, O., BOUVIER, A.M., FAIVRE, J., BOUTREUX, S., PUYOU DE POUVOURVILLE, G. and LAUNOY, G. (2008). Access to Care, Socioeconomic Deprivation and Colon Cancer Survival. Alimentary Pharmacology & Therapeutics, 27(10), pp. 940-949.
- BORGET, I., VIELH, P., LEBOULLEUX, S., ALLYN, M., IACOBELLI, S. and DE POUVOURVILLE, G. (2008). Assessment of the Cost of Fine-needle Aspiration Cytology as a Diagnostic Tool in Patients with Thyroid Nodules. American Journal of Clinical Pathology, 129(5), pp. 763-771.
- PUYOU DE POUVOURVILLE, G., SOLESSE, A. and BEILLAT, M. (2008). Cost-effectiveness Analysis of Aldosterone Blockade with Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction in the French Context: The EPHESUS Study. Archives of Cardiovascular Diseases, 101(9), pp. 515-521.
- BONASTRE, J., CHEVALIER, J., ELIAS, D., CLASSE, J.M., FERRON, G. and DE POUVOURVILLE, G. (2008). Cost-effectiveness of Intraperitoneal Chemohyperthermia in the Treatment of Peritoneal Carcinomatosis from Colorectal Cancer. Value in Health, 11(3), pp. 347-353.
- CLERC, P., LEBRETON, J., MOUSQUES, J., HEBBRECHT, G. and PUYOU DE POUVOURVILLE, G. (2008). Etude polychrome : construction d'une typologie des pathologies chroniques en médecine générale, pour une analyse de la poly-prescription. Pratiques et Organisation des Soins, 39(1), pp. 43-51.
- BORGET, I., REMY, H., CHEVALIER, J., RICARD, M., ALLYN, M. and DE POUVOURVILLE, G. (2008). Length and Cost of Hospital Stay of Radioiodine Ablation in Thyroid Cancer Patients: Comparison between Preparation with Thyroid Hormone Withdrawal and Thyrogen. European Journal of Nuclear Medicine and Molecular Imaging, 35(8), pp. 1457-1463.
- COTTE, F.E., MERCIER, F. and PUYOU DE POUVOURVILLE, G. (2008). Relationship Between Compliance and Persistence with Osteoporosis Medications and Fracture Risk in Primary Health Care in France: A Retroprospective Case-control Analysis. Clinical Therapeutics, 30(12), pp. 2410-2422.
- TIBI-LEVY, Y., PUYOU DE POUVOURVILLE, G., WESTERLOPPE, J. and BAMBERGER, M. (2008). The Cost of Treating High Blood Pressure in General Practice in France. European Journal of Health Economics, 9(3), pp. 229-236.
- PUYOU DE POUVOURVILLE, G. (2007). Editorial : La réforme de la gouvernance hospitalière : mission impossible? La Presse Médicale, 36(4), pp. 636-637.
- PUYOU DE POUVOURVILLE, G., BORGET, I. and SCHLUMBERGER, M. (2007). Health-related Quality of Life - An Economist's Perspective (Viewpoint). Nature Reviews Endocrinology, 3(12), pp. 2-3.
- SCHLUMBERGER, M., RICARD, M., PUYOU DE POUVOURVILLE, G. and PACINI, F. (2007). How the Availability of Recombinant Human TSH Has Changed the Management of Patients Who Have Thyroid Cancer. Nature Reviews Endocrinology, 3(9), pp. 641-650.
- PUYOU DE POUVOURVILLE, G. (2007). Qu'est-ce que la recherche en médecine générale ? La Revue du Practicien, 57(11), pp. 1181-1185.
- DE POUVOURVILLE, G., BORGET, I. and SCHLUMBERGER, M. (2007). Calcitonin determination in patients with nodular thyroid disease. The Journal of Clinical Endocrinology & Metabolism, 92(2), pp. 425-427.
- DE POUVOURVILLE, G., BONASTRE, J., DE BAÈRE, T., ELIAS, D. and SERGE, E. (2007). Cost of radiofrequency ablation in the treatment of hepatic malignancies. Gastroentérologie Clinique et Biologique, 31, pp. 828-835.
- DE POUVOURVILLE, G. and SPIELER, J.F. (2007). Evaluation du coût de la prise en charge ambulatoire des patients après AVC: résultats d'une enquête postale auprès des patients du registre des AVC de Dijon. La Presse Médicale, 36(3), pp. 399-403.
- DE POUVOURVILLE, G., HALLAIS, C., CZERNICHOW, P., LE VAILLANT, M. and FROMENT, L. (2007). Gravité des patients et surcoüts dans les hôpitaux de référence. Journal d'Economie Médicale, 25(3), pp. 177-187.
- DE POUVOURVILLE, G., BORGET, I. and SCHLUMBERGER, M. (2007). Health-related quality of life- an economist's perspective. Nature Clinical Practice Endocrinology & Metabolism, 3, pp. 786-787.
- DE POUVOURVILLE, G. and PRIOLLET, P. (2007). Impact du choix d'une thérapie anti-agrégante dans l'artériopathie des membres inférieurs: étude coût-efficacité et impact économique. Journal des Maladies Vasculaires, 32(1), pp. 8-14.
- BONASTRE, J., CHEVALIER, J., GÉRARD, J.P., LEFKOPOULOS, D. and DE POUVOURVILLE, G. (2007). Implications of learning effects for hospital costs of new technologies: the case of intensity modulated radiation therapy. International Journal of Technology Assessment in Health Care, 23(2), pp. 248-254.
- DE POUVOURVILLE, G. (2007). La recherche en médecine générale en France: état es lieux. La Revue du Practicien, 57(11), pp. 1200-1202.
- DE POUVOURVILLE, G. (2007). Réformer la gouvernance de l'hôpital: mission impossible? La Presse Médicale, 36(4), pp. 636-637.
- DE POUVOURVILLE, G., BORGET, I., CORONE, C., NOCAUDIE, M. and ALLYN, M. (2007). Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. European Journal of Endocrinology, 156(5), pp. 531-538.
- DE POUVOURVILLE, G., TIBI-LÉVY, Y., BAMBERGER, M. and WESTTERLOPPE, J. (2007). The cost of treating high blood pressure in France. European Journal of Health Economics.
Book editor
Book chapters
- PUYOU DE POUVOURVILLE, G. (2021). La fabrication du prix du médicament. In: Thomas Barnay, Anne-Laure Sanson, Bruno Ventelou eds. Le système de santé français : aujourd'hui. Enjeux et défis. 1st ed. ESKA.
- PUYOU DE POUVOURVILLE, G. (2021). Trente ans de dépenses de santé en France. In: René Demeleumeester, Jean-Calude Henrard, Bernadette Roussille, Patricia Siwek eds. Trente ans d'évolution de la santé en France : À quoi ont servi les politiques de santé ? 1st ed. Boulogne-Billancourt: Berger-Levrault, pp. 255-270.
- PUYOU DE POUVOURVILLE, G. (2021). Trente ans d’administration et de financement du système de soins. In: René Demeleumeester, Jean-Calude-Henrard, Bernadette Roussille, Patricia Siwek eds. Trente ans d'évolution de la santé en France : À quoi ont servi les politiques de santé ? 1st ed. Boulogne-Billancourt: Berger-Levrault, pp. 125-140.
- PUYOU DE POUVOURVILLE, G., CONTI, C. and BIBAULT, E. (2009). La distribution du médicament en France. In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 427-434.
- PUYOU DE POUVOURVILLE, G. (2009). Le financement des hôpitaux. In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 269-274.
- PUYOU DE POUVOURVILLE, G. (2009). L'économie de la santé : périmètre et questions de recherche. In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 15-24.
- PUYOU DE POUVOURVILLE, G., BRAS, P.L. and TABUTEAU, D. (2009). L'industrie pharmaceutique en France. In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 415-426.
- PUYOU DE POUVOURVILLE, G. (2009). L'organisation des soins. In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 401-406.
- D'AUNNO, T., KIMBERLY, J. and PUYOU DE POUVOURVILLE, G. (2008). Conclusions: The Global Diffusion of Casemix. In: The Globalization of Managerial Innovation in Health Care. 1st ed. Cambridge University Press, pp. 346-372.
- PUYOU DE POUVOURVILLE, G. (2007). Les conséquences économiques des droits des malades. In: Les droits des malades et des usagers du système de santé, une législature plus tard. 1st ed. Presses de Sciences Po, pp. 53-58.
Conference proceedings editor
Conference Proceedings
- PUYOU DE POUVOURVILLE, G. (2016). Le territoire dans la régulation du système de santé. In: Management hospitalier et territoire: les nouveaux défis. Presses des Mines.
- FEARON, W., BORNSCHEIN, B., ARVANDI , M., GOTHE, R., RIOUFOL, G., DE BRUYNE, B. ... SIEBERT, U. (2011). Cost-effectiveness of fractional flow reserve measurement in multivessel coronary artery disease in Belgium and in France. In: ISPOR Europe. Value in Health, pp. 251.
Interviews: radio, TV, press
Teaching
- 2014 - 2018 : Msc in Management of Health Industries ( ESSEC Business School Singapore)
- 2013 - 2017 : Hospital Management program (Management Général ESSEC Business School France)
- 2012 - 2015 : Heattl Technology assessmentin Asia Pacific ( ESSEC Business School Singapore)
- 2007 - 2019 : Health care Systems- Health product mrketing (Grande Ecole - Master in Management ESSEC Business School France)
Professional activities
- 1950 : - Present : Invited Expert, Ministère de la Santé et du Bien-être, Province d’Alberta, Canada., Canada
- 1950 : - Present : Member of the Global Health Outcome Board, Groupe Glaxo-Smith-Kline
- 1992 : - Present : Member of the Groupe de Prospective Santé 2010, Commissariat Général au Plan ; writer of the health system regulation regionalization scenario (Rapport Santé 2010, under the supervision of Raymond Soubie) ; to this end writer of a synthesis presenting a creation project of Health Regional Agencies.
- 1950 : - Present : Member of theCommission des Comptes de la Santé
- 1950 : - Present : Scientific expert for the Mission Tarification à l’Activité, Ministère de la Santé- Participation in the working group on the topic : Financement des Missions d’Intérêt Général et d’Aide à la Contractualisation, France
- 2004 : Member of the Comité d’Experts, Tarification à l’Activité, Ministère de la Santé
- 1950 : - Present : Consultant for the laboratories: MSD, Sanofi-Aventis, Astra-Zeneca, Pfizer, Servier, Procter& Gamble, BMS, Bayer SA.
- 1950 : - Present : Consultant, Centre Hospitalier Régional Universitaire de Lille, evaluation of the Missions d’Intérêt Général et d’Aide à la Contractualisation, as part of the Tarification à l’Activité., France
- 1950 : - Present : For the Ministre de la Santé and the Ministre Délégué à la Recherche, about the development of general medicine research in France., France
- 2004 : Consultant for Centre Hospitalier de Lagny-Marne-la-Vallée: implementation of intern contractualization
- 2003 : Expert for the Royal Commission for the reform of the Canadian Health System (Romanow Commission)
- 2001 - 2003 : Vice-President of the Comité d'Orientation, Observatoire des Prescriptions et de la Consommation des Médicaments, Ministère de la Solidarité Nationale, de l'Emploi et de la Santé.
- 1982 - 1996 : Consultant for the Direction des Hôpitaux, Ministère de la Santé; conception of medical information systems for hospitals, in charge of the development of a budgetization method based on the medical activity of the establishments ; participation in the writing of Etude Nationale des Coûts.
- 1983 - 1984 : Consultant for Direction Générale de la Santé, Ministère de la Santé; expert for the Commission Nationale d'Anesthésiologie about specialty demography regulation.
- 1974 : Consultant for OECD, on the project "Politiques pour l'innovation dans le secteur des services".
Member of an professional association, of an expert group or of a board of directors
Consulting
Research activities
- 2016 - 2018 : Editorial board membership - Gérer et Comprendre
- Reviewer for European Journal of Health Economics; Gérer et Comprendre; Health Economics; International Journal of Technology Assessment in Health Care; Pharmacoeconomics; Politiques et Management Public; Revue Française de Gestion; Social Science and Medicine
- 1989 - 1998 : Organization and co-organization of 8 symposia and research seminars, 3 of them as a member of the scientific committee of "mini-symposia" INSERM
- 2000 - 2006 : Coordinator of the Comité d'Interface INSERM/Médecine Générale
- 2001 - 2006 : Member of the Comité Directeur of IFR "Epidémiologie, Santé Publique, Sciences Sociales"
- 2000 - 2006 : Member of the Comité Scientifique Sciences Humaines et Sociales, Institut National du Cancer.
- 2002 - 2005 : Designated member of the board of directors of INSERM
- 2000 - 2005 : President of the Collège des Economistes de la Santé, member of the Conseil d’Administration , hence scientific supervisor of the organization of two international symposia ; promoter of the basis of the documentary « Connaissance et Décision en Economie de la Santé », creator of the European network (16 countries) of documentary databases in Health Economics "EURONHEED" ; co-supervisor of the writing of « Recommandations pour l’évaluation économique des stratégies de santé »., France
- 1995 - 2000 : Elected member of the Comité National, section 37 « Economie et Société »
- 1998 - 2000 : Member of the Scientific Council of Institut Paoli Calmettes
- 1997 - 2000 : Member of the Scientific Council of Institut Universitaire de Santé Publique of Ile de France
- 1995 - 1999 : Member of the Scientific Council of Ecole Nationale de la Santé Publique
- 1995 - 1998 : Member of the Scientific Council of Institut d'Etude des Politiques de Santé, Paris V.
- 1998 : Member of the scientific evaluation mission of Agence Nationale de Recherche sur le SIDA, Ministère de la Recherche et de la Technologie.
- 1996 - 1998 : Scientific supervisor of the France-Québec scientific cooperation program" Economie de la Santé ".
- 1990 - 1995 : Designated member of the Scientific Council of INSERM
- 1992 - 1994 : Scientific Committee President of the invitation to tender "Evaluation Economique des Stratégies Préventives et Thérapeutiques", Ministère de la Recherche
- 1950 : - Present : Member of the Scientific Council of Mission Innovation, Recherche et Expérimentation (MIRE), DREES, Ministère de la Santé, France
- 1995 : - Present : Member of the Scientific Council of l’Institut de Recherche et de Documentation en Economie de la Santé (IRDES), Caisse Nationale d'Assurance Maladie, France
- 1950 : - Present : Member of the Steering Committee on research operations of Haute Autorité de Santé, France
- 1950 : - Present : Member of the International Health Economics Association (IHEA)
Editorial Board Membership
Reviewer for a journal
Organization of a conference or a seminar
Function in an academic association
Role as an expert or appraisor in a research organization
Member of an academic association
Theses
- 2020 : (University Paris-Saclay), Thesis director
- 2019 : (Université Paris Descartes (Paris V)), Thesis referee
- 2018 : (University Paris-Saclay), Thesis referee
- 2017 : (University Paris-Saclay), Thesis director
- 2016 : (University Paris-Saclay), Thesis jury member
- 2016 : (Université Paris-Dauphine, PSL University), Thesis referee
- 2016 : (Université Paris-Dauphine, PSL University), Thesis jury member
- 2016 : (Université de Bourgogne), Thesis referee
- 2016 : (Université Paris Est Créteil), Thesis jury member
- 2016 : (Université Lyon 2), Thesis jury member
- 2015 : (Université Pierre et Marie Curie (UPMC)), Thesis referee
- 2015 : (Université Paris 1 Panthéon-Sorbonne), Thesis referee
- 2014 : (Université Paris-Dauphine, PSL University), Thesis referee
- 2013 : (Université Paris-Dauphine, PSL University), Thesis referee
- 2012 : (University Paris-Saclay), Thesis jury member
- 2012 : (Université Paris 1 Panthéon-Sorbonne), Thesis jury president
- 2011 : (Université Paris-Dauphine, PSL University), Thesis referee
- 2010 : (Université Paris-Dauphine, PSL University), Thesis referee
- 2010 : (Université d'Aix-Marseille), Thesis referee
- 2010 : (Université Paris-Dauphine, PSL University), Thesis director
- 2009 : (University Paris-Saclay), Thesis director
- 2009 : (University Paris-Saclay), Thesis director
- 2008 : (Université d'Aix-Marseille), Thesis referee
- 2008 : (Université Pierre et Marie Curie (UPMC)), Thesis referee
- 2008 : (University Paris-Saclay), Thesis director
- 2007 : (Université Paris-Dauphine, PSL University), Thesis director
- 2007 : (University Paris-Saclay), Thesis director
- 2007 : (University Paris-Saclay), Thesis director
- 2007 : (University Paris-Saclay), Thesis director
- 2007 : (University Paris-Saclay), Thesis co-director
- 2004 : (University of Caen), Thesis jury member
- 2003 : (Université Paris-Diderot (Paris VII)), Thesis director
- 2003 : (Université Paris 1 Panthéon-Sorbonne), Thesis director
- 2003 : (Université Paris-Diderot (Paris VII)), Thesis director
- 2003 : (École Polytechnique), Thesis director
- 2002 : (Université Paris-Diderot (Paris VII)), Thesis director
- 2001 : (Université Paris-Diderot (Paris VII)), Thesis director
- 1999 : (École Polytechnique), Thesis director, First placement: Conseil en entreprise
- 1999 : (University Paris-Saclay), Thesis director
- 1999 : (Université Paris-Diderot (Paris VII)), Thesis director
- 1998 : (École Polytechnique), Thesis director
- 1998 : (Institut d'Etudes Politiques), Thesis jury member
- 1997 : (Université Toulouse III Paul Sabatier), Thesis jury member
- 1997 : (Université de Bourgogne), Thesis jury member
- 1996 : (École Polytechnique), Thesis director
- 1995 : (IUT Sceaux - Université Paris Sud), Thesis co-director
- 1994 : (Université d'Aix-Marseille), Thesis director
- 1994 : (École Polytechnique), Thesis director, First placement: Université de Grenoble
- 1992 : (École Polytechnique), Thesis director, First placement: INRA
- 1992 : (École Polytechnique), Thesis director
- 1988 : (École Polytechnique), Thesis director
- Ongoing : (EHESS - École des hautes études en sciences sociales), Thesis referee